Not Yet RecruitingNot Applicable

Conservative Versus Surgical Treatment of Gartland Type II Supracondylar Humeral Fractures in Children - Which One ?

50 participantsStarted 2026-06-01

Plain-language summary

The primary aim of this research is to compare the efficacy of conservative treatment versus surgical treatment for Gartland type II supracondylar humerus fractures in children. The comparison focuses on assessing differences in clinical outcomes functional recovery times, and complication rates between the two treatment groups.

Who can participate

Age range1 Year – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with Gartland type II supracondylar humerus fractures with age between 1-12 years old treated at the AUH Exclusion Criteria: * Gartland Type I, III, or IV fractures. * Open fractures. * Associated neurovascular injury (e.g., absent radial pulse, documented nerve palsy). * Patients with another injury in the same limb * Pathological fractures. * Pre-existing elbow pathology or congenital deformity. * Inability to comply with follow-up protocol.

What they're measuring

Functional outcome assessed by Modified Disabilities of the Arm, Shoulder and Hand (QuickDASH) score

Timeframe: 1 year

Trial details

NCT IDNCT07558941

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-06-01

View on ClinicalTrials.gov More Humeral Fractures trials